- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.58 Å
- Oligo State
- monomer
- Ligands
- 1 x DUH: 2-oxidanyl-~{N}-[2,3,5,6-tetrakis(fluoranyl)-4-phenyl-phenyl]pyrazolo[1,5-a]pyridine-3-carboxamide(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 1 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)
FMN.4: 25 residues within 4Å:- Chain A: A.94, A.95, G.96, K.99, G.118, S.119, N.144, Y.146, N.180, N.211, K.254, T.282, N.283, T.284, S.304, G.305, L.308, V.332, G.333, G.334, L.354, Y.355, T.356
- Ligands: DUH.1, ORO.11
21 PLIP interactions:21 interactions with chain A- Hydrophobic interactions: A:N.144, A:Y.146, A:Y.355
- Hydrogen bonds: A:A.95, A:K.99, A:S.119, A:S.119, A:N.180, A:N.211, A:K.254, A:K.254, A:N.283, A:S.304, A:G.305, A:G.334, A:Y.355, A:T.356, A:T.356
- Water bridges: A:A.95, A:G.333, A:V.335
- 6 x ACT: ACETATE ION(Non-functional Binders)
ACT.5: 6 residues within 4Å:- Chain A: Q.167, A.168, T.171, L.204, A.205, D.206
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:Q.167
- Hydrogen bonds: A:T.171
- Water bridges: A:A.168
ACT.6: 5 residues within 4Å:- Chain A: R.240, D.241, R.248, L.274, G.275
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.248
- Water bridges: A:R.240
- Salt bridges: A:R.240
ACT.7: 1 residues within 4Å:- Chain A: R.245
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:R.245
ACT.8: 2 residues within 4Å:- Chain A: K.306, P.307
No protein-ligand interaction detected (PLIP)ACT.9: 2 residues within 4Å:- Chain A: H.40, T.44
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:H.40
ACT.10: 1 residues within 4Å:- Chain A: R.145
2 PLIP interactions:2 interactions with chain A- Water bridges: A:R.145
- Salt bridges: A:R.145
- 1 x ORO: OROTIC ACID(Non-covalent)
ORO.11: 10 residues within 4Å:- Chain A: K.99, N.144, R.145, Y.146, G.147, F.148, N.211, N.283, T.284
- Ligands: FMN.4
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:F.148
- Hydrogen bonds: A:N.144, A:N.144, A:N.144, A:G.147, A:F.148, A:N.211, A:N.283, A:N.283
- Salt bridges: A:K.99
- 4 x GOL: GLYCEROL(Non-functional Binders)
GOL.12: 4 residues within 4Å:- Chain A: G.275, I.276, D.277, R.326
4 PLIP interactions:4 interactions with chain A- Water bridges: A:G.275, A:G.275, A:D.277, A:D.277
GOL.13: 3 residues within 4Å:- Chain A: A.70, Y.108, K.109
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:K.109
GOL.14: 4 residues within 4Å:- Chain A: E.126, G.127, N.128, R.130
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:E.126, A:N.128
- Water bridges: A:E.126, A:R.130, A:R.132
GOL.15: 3 residues within 4Å:- Chain A: P.122, K.123, E.196
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:E.196
- 6 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
PGE.16: 8 residues within 4Å:- Chain A: H.100, P.124, Q.125, E.126, N.149, S.150, H.151
- Ligands: PGE.17
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:N.149
- Water bridges: A:H.100, A:E.126, A:R.132, A:H.151
PGE.17: 5 residues within 4Å:- Chain A: P.124, H.151, V.155, R.159
- Ligands: PGE.16
No protein-ligand interaction detected (PLIP)PGE.18: 5 residues within 4Å:- Chain A: D.50, E.52, S.53, R.56, R.130
2 PLIP interactions:2 interactions with chain A- Water bridges: A:E.52, A:E.52
PGE.19: 5 residues within 4Å:- Chain A: R.81, G.325, R.326, P.328, S.350
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.81, A:S.350
PGE.20: 7 residues within 4Å:- Chain A: L.83, G.84, R.240, R.245, R.248, P.249, D.277
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.248
- Water bridges: A:A.250
PGE.21: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sainas, S. et al., Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors. J. Med. Chem. (2018)
- Release Date
- 2018-07-11
- Peptides
- Dihydroorotate dehydrogenase (quinone), mitochondrial: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.58 Å
- Oligo State
- monomer
- Ligands
- 1 x DUH: 2-oxidanyl-~{N}-[2,3,5,6-tetrakis(fluoranyl)-4-phenyl-phenyl]pyrazolo[1,5-a]pyridine-3-carboxamide(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 1 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)
- 6 x ACT: ACETATE ION(Non-functional Binders)
- 1 x ORO: OROTIC ACID(Non-covalent)
- 4 x GOL: GLYCEROL(Non-functional Binders)
- 6 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sainas, S. et al., Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors. J. Med. Chem. (2018)
- Release Date
- 2018-07-11
- Peptides
- Dihydroorotate dehydrogenase (quinone), mitochondrial: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A